Application Type
National
Application SubType
(10) Registration Number and Date
10202402498Y
Status
ACTIVE ( Other event occurred)
(180) Expiration Date
(20) Filing Number and Date
SG 10202402498Y 2023.12.31
(40) Publication Number (Gazette Number) and Date
(85) National Entry Date
(30) Priority Details
US
US63/236,215
2020.12.27
(51) IPC Classes
(71/73) Applicant
(72) Inventor
(74) Representative
(54) Title
(57) Abstract
(EN) ABSTRACT The present disclosure provides nucleic acid molecules comprising a first inverted terminal repeat (ITR), a second ITR, and a genetic cassette encoding a target sequence. In some embodiments, the first ITR and/or the second ITR is an ITR of human bocavirus. Also disclosed are methods of using the nucleic acid molecules in gene therapy applications. [No Figure] 102
(58) Citations
License Details
(98) Annuity Details
| Year | Validity Start | Validity End | Payment |
|---|
